Article
Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants.
PloS one - 1 Jan 2022
Chuaypen Natthaya, Siripongsakun Surachate, Hiranrat Pantajaree, Tanpowpong Natthaporn, Avihingsanon Anchalee, Tangkijvanich Pisit
Abstract excerpt
Significant liver fibrosis regression occurs after hepatitis C virus (HCV) therapy. However, the impact of direct-acting antivirals (DAAs) on steatosis is less clear. This study was aimed at evaluating serial fibrosis and steatosis alterations in patients with HCV genotype 1, who achieved sustained virological response (SVR). We enrolled 55 HCV mono-infected and 28 HCV/HIV co-infected patients receiving...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
